HAL (France)open access
Health-Related Quality of Life with Pembrolizumab in Patients with Locally Advanced or Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: KEYNOTE-629
Immunotherapy, Quality of life, 0, Advanced squamous cell carcinoma, Pembrolizumab
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 137445
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.